Delivery Order SPE2DB25D3201-SPE2DB25FNVXW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,062.90 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections on September 22, 2025, with an ultimate completion date of September 23, 2025. This award was made under firm fixed-price terms with no set-aside designation, indicating competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a discrete...
- The Defense Logistics Agency awarded a $42,104.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 mL pen injections on July 28, 2025, with completion targeted for July 29, 2025. This non-set-aside award represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $2,178.52 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen injections on June 24, 2025, with completion targeted for June 25, 2025. This competitively awarded, firm fixed-price delivery order represents fulfillment under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $6,561.48 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injectors on September 4, 2025, with an ultimate completion date of September 5, 2025. This firm fixed price delivery order, which carries no set-aside designation, is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $6,021.03 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections on August 25, 2025, with completion targeted for August 26, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,863.77 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen injections on August 11, 2025, with completion targeted for August 12, 2025. This delivery order utilizes firm fixed pricing with no set-aside designation, indicating the award was made through open competition. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the...
- The Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award executed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $18,301.92 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injectors on September 10, 2025, with completion targeted for September 11, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award to the pharmaceutical distributor, which is headquartered in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,083.86 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injections on September 24, 2025. This contract utilizes firm fixed pricing and was competitively awarded without any set-aside designation. The award was fulfilled by AmerisourceBergen's Corporate Office division, with performance at the company's headquarters in Conshohocken, Pennsylvania. The delivery order is scheduled for completion by September 25,...
- The Defense Logistics Agency awarded a delivery order valued at $9,119.37 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 ml pen injections on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNVXWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,856.00 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 ml pen injections on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems through DLA's Medical Supply Chain. As a critical vendor for the Defense Health Agency and U.S. Coast Guard, the company supplies an extensive portfolio of pharmaceutical products across multiple therapeutic domains. The Zepbound delivery order reflects AmerisourceBergen's role in supporting federal healthcare requirements for specialty medications under the comprehensive global pharmaceutical support vehicle administered by DLA Troop Support, which is planning to establish generation V contracts with multiple regional awards in the coming period.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 8/26/25 |